Desjardins Global Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Desjardins Global Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$263K	Buy	18,930 +1,275	+7%	+$17K	0.03%	314
2023 Q3	$236K	Buy	17,655 +4,465	+34%	+$60.4K	0.03%	344
2023 Q2	$166K	Hold	13,190	–	–	0.02%	453
2023 Q1	$150K	Hold	13,190	–	–	0.02%	434
2022 Q4	$137K	Hold	13,190	–	–	0.02%	375
2022 Q3	$138K	Sell	13,190 -14,640	-53%	-$156K	0.02%	372
2022 Q2	$308K	Buy	27,830 +4,690	+20%	+$51K	0.04%	292
2022 Q1	$257K	Buy	23,140 +1,845	+9%	+$20.9K	0.02%	339
2021 Q4	$278K	Buy	+21,295	New	+$268K	0.02%	341

Other funds holding RDY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Desjardins Global Asset Management's RDY Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Dr. Reddy's Laboratories (RDY) stake by 7.2% in Q4 2023, buying an estimated $17K and bringing the position to 18,930 shares worth $263K. The position accounts for 0.03% of the portfolio, ranked #314.

Desjardins Global Asset Management first reported a position in RDY in Q4 2021 and has held it in 9 quarters since. The position peaked at $308K in Q2 2022. 223 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

Desjardins Global Asset Management held 18,930 shares of Dr. Reddy's Laboratories worth $263K as of Q4 2023.
Desjardins Global Asset Management bought 1,275 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $17K.
Dr. Reddy's Laboratories made up 0.03% of Desjardins Global Asset Management's portfolio in Q4 2023, its #314 holding.
Desjardins Global Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Dr. Reddy's Laboratories position peaked at $308K in Q2 2022.
223 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.